Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial

BACKGROUND: Increasing the biological effective dose (BED) of radiotherapy for non-small cell lung cancer (NSCLC) can increase local control rates and improve overall survival. Compared with conventional fractionated radiotherapy, accelerated hypofractionated radiotherapy can yield higher BED, short...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiao-Cang, Wang, Quan-Yu, Zhang, Rui, Chen, Xue-Ji, Wang, Na, Liu, Yue-E, Zong, Jie, Guo, Zhi-Jun, Wang, Dong-Ying, Lin, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842268/
https://www.ncbi.nlm.nih.gov/pubmed/27108080
http://dx.doi.org/10.1186/s12885-016-2314-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842268/
https://www.ncbi.nlm.nih.gov/pubmed/27108080
http://dx.doi.org/10.1186/s12885-016-2314-1

Ejemplares similares